Kovai Medical Center & Hospital Ltd

Kovai Medical Center & Hospital Ltd

₹ 4,210 1.90%
21 Jun - close price
About

Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]

Key Points

Hospital Portfolio
The company operates peripheral centers in Coimbatore, Sulur, Coimbatore (city center), Erode, and Kovilpalayam, along with hospitals having a combined capacity of approximately 2250 beds. [1]

  • Market Cap 4,605 Cr.
  • Current Price 4,210
  • High / Low 4,777 / 2,202
  • Stock P/E 25.6
  • Book Value 812
  • Dividend Yield 0.12 %
  • ROCE 22.3 %
  • ROE 22.4 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 24.5% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
199 239 218 229 220 236 252 264 267 275 303 321 321
141 164 154 165 166 174 184 193 200 206 217 225 229
Operating Profit 58 75 64 64 54 62 68 71 67 68 85 96 92
OPM % 29% 31% 29% 28% 25% 26% 27% 27% 25% 25% 28% 30% 29%
5 2 2 4 3 4 3 4 5 6 4 5 6
Interest 9 11 11 11 10 10 10 10 10 10 8 7 7
Depreciation 18 19 23 22 21 23 22 22 22 22 23 23 24
Profit before tax 36 47 32 36 26 32 39 43 41 42 58 71 67
Tax % 26% 25% 25% 27% 28% 27% 23% 27% 25% 26% 26% 25% 22%
27 35 24 26 19 24 30 31 31 31 43 53 52
EPS in Rs 24.55 32.19 22.07 23.82 17.20 21.74 27.67 28.46 27.93 28.38 39.67 48.53 47.69
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
297 334 402 465 531 588 628 712 690 905 1,020 1,220
227 261 307 374 406 459 494 540 495 645 746 878
Operating Profit 70 73 94 92 125 129 135 171 195 261 274 342
OPM % 24% 22% 23% 20% 23% 22% 21% 24% 28% 29% 27% 28%
3 5 7 8 6 7 8 10 12 12 14 21
Interest 27 24 20 17 15 13 15 18 33 46 43 33
Depreciation 15 16 21 21 24 34 36 52 68 85 89 92
Profit before tax 31 37 59 62 92 89 93 112 106 141 155 238
Tax % 32% 36% 35% 35% 35% 35% 35% 15% 27% 26% 25% 24%
21 24 39 40 60 58 60 95 78 104 116 180
EPS in Rs 19.42 21.68 35.37 36.95 54.81 52.99 54.96 86.44 71.00 95.28 105.80 164.25
Dividend Payout % 8% 7% 4% 7% 5% 6% 5% 3% 4% 6% 9% 0%
Compounded Sales Growth
10 Years: 14%
5 Years: 14%
3 Years: 21%
TTM: 20%
Compounded Profit Growth
10 Years: 22%
5 Years: 24%
3 Years: 32%
TTM: 53%
Stock Price CAGR
10 Years: 33%
5 Years: 43%
3 Years: 46%
1 Year: 89%
Return on Equity
10 Years: 21%
5 Years: 20%
3 Years: 20%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 11 11 11 11 11 11 11 11 11 11 11 11
Reserves 70 91 127 165 224 276 332 420 499 598 708 878
209 184 163 158 125 202 378 543 623 550 511 310
55 65 85 96 103 116 129 134 148 184 213 239
Total Liabilities 345 351 386 430 464 605 850 1,108 1,281 1,343 1,443 1,438
279 277 281 337 354 443 469 643 1,033 1,085 1,088 1,118
CWIP 5 5 17 10 6 13 227 300 45 5 23 39
Investments 4 4 4 4 4 0 0 0 0 0 0 0
57 65 85 78 100 149 153 165 203 253 331 281
Total Assets 345 351 386 430 464 605 850 1,108 1,281 1,343 1,443 1,438

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
62 68 97 85 99 87 126 152 186 262 263 344
-9 -12 -80 -113 -83 -192 -352 -335 -180 -292 -358 -138
-48 -52 -43 -24 -50 60 160 113 38 -119 -86 -243
Net Cash Flow 6 4 -26 -53 -33 -45 -66 -70 44 -149 -180 -38

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 5 8 9 7 8 8 6 4 7 8 9 5
Inventory Days 35 33 25 22 20 23 20 23 19 19 18 17
Days Payable 29 35 53 47 37 43 47 46 29 20 35 30
Cash Conversion Cycle 11 6 -19 -19 -9 -12 -21 -19 -2 6 -8 -8
Working Capital Days -49 -43 -56 -52 -47 -48 -49 -36 -38 -38 -38 -42
ROCE % 20% 21% 27% 25% 31% 24% 18% 15% 13% 16% 17%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
55.76% 55.74% 55.74% 55.71% 55.76% 55.76% 55.76% 55.98% 56.26% 56.43% 56.44% 56.47%
2.08% 2.08% 2.09% 2.13% 2.12% 2.14% 2.15% 2.18% 2.20% 2.25% 2.24% 0.34%
1.43% 1.72% 1.77% 1.95% 1.95% 1.92% 1.97% 2.07% 2.19% 2.09% 2.09% 4.18%
40.73% 40.46% 40.40% 40.21% 40.17% 40.19% 40.12% 39.79% 39.34% 39.24% 39.24% 39.02%
No. of Shareholders 10,0769,9519,5179,6889,5599,5449,4649,67410,48710,73010,33811,918

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents